Not available
Quote | Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)
Last: | $38.99 |
---|---|
Change Percent: | -0.47% |
Open: | $42.36 |
Close: | $38.99 |
High: | $43.235 |
Low: | $37.61 |
Volume: | 3,353,067 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)
2024-04-19 23:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-18 06:12:57 ET More on Biohaven Biohaven's Bounce Back: A Missed Call Turns Bullish (Rating Upgrade) Biohaven stock slides 15% amid data presentations RBC Capital starts Biohaven at outperform, cites epilepsy drug Read the full article on Seeking Al...
Message Board Posts | Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $BHVN hod15.09 ML12.41 HH17.86 thin >17 | znewcar1 | investorshangout | 01/09/2023 3:10:05 PM |
znewcar1: $BHVN lod=ML12.41 MH17.86 a bo13 looks to have failed does $12.4 hold? or is this the star | znewcar1 | investorshangout | 12/28/2022 6:30:40 PM |
znewcar1: HOD16.4 $BHVN | znewcar1 | investorshangout | 10/31/2022 4:37:11 PM |
znewcar1: HOD15.45 S@14.1? $BHVN | znewcar1 | investorshangout | 10/24/2022 1:55:20 PM |
Long I love the move after the offering, | simmons420 | investorshub | 10/22/2022 9:49:46 AM |
News, Short Squeeze, Breakout and More Instantly...
Biohaven Pharmaceutical Holding Company Ltd. Company Name:
BHVN Stock Symbol:
NYSE Market:
2024-04-19 23:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares PR Newswire NEW HAVEN, Conn. , April 18, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of l...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...